A CR on the current SP is, in my opinion, the worst thing to do....

A CR on the current SP is, in my opinion, the worst thing to do.

Why a CR now - there should be enough funds to reach the major milestone of "Enrollment Complete" around June this year. By that time a large number of enrolled patients, around half of the sample, should have completed the trial's base and there is the possibility that enough vibes have escaped or are escaping making the outlook smelling good. The majority of posters here is obviously convinced that this is a superior product hence the reasoning above.
Therefore: Why doing a CR now at this SP stage when the picture may look much better in a few month's time. Surely, the directors could suspend their fees for a quarter or so in case some funds are needed.

As I have said before this company is in urgent need of share consolidation - 10:1 at least.
Such a consolidation will give a good new SP on which any future CR should be based. At the same time couple that with a buy-back of unmarketable parcels and the cleanup would be done.